MA: Houghton‐Mifflin, 1977.
332 332. Hsia YE, Hirschhorn K, Silverberg RL, et al. Counseling in genetics. New York: Alan R. Liss, 1979.
333 333. Lewis C, Mehta P, Kent A, et al. An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries. Eur J Hum Genet 2007; 15:1012.
334 334. Frets PG, Duivenvoorden HJ, Verhage F, et al. Factors influencing the reproductive decision after genetic counselling. Am J Med Genet 1990; 35:496.
335 335. Milunsky A. How to have the healthiest baby you can. New York: Simon & Schuster, 1987.
336 336. Kung JT, Gelbart, ME. Getting a head start: the importance of personal genetics education in high schools. Yale J Biol Med 2012; 85:87.
337 337. Milunsky A. Choices, not chances: an essential guide to your heredity and health. Boston, MA: Little, Brown, 1989.
338 338. Milunsky A. Heredity and your family's health. Baltimore, MD: Johns Hopkins University Press, 1992.
339 339. Milunsky A. Your genes, your health: a critical family guide that could save your life. Oxford: Oxford University Press, 2012.
340 340. Mersch J, Brown N, Pirzadeh‐Miller S, et al. Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA 2018; 320(12):1266.
341 341. Cantebury v. Spence, 464 F.2d 772 (D.C. Cir. 1972).
342 342. Carrieri D, Dheensa S, Doheny S, et al. Recontacting in clinical practice: the views and expectations of patients in the United Kingdom. Eur J Hum Genet 2017; 25:1106.
343 343. Laurie G. Privacy and the right not to know: a plea for conceptual clarity. In: Ruth C, Mairi L, Darren S, eds. The right to know and the right not to know: genetic privacy and responsibility. Cambridge: Cambridge University Press, 2014: 38.
344 344. Committee of the International Huntington Association and the World Federation of Neurology. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994; 31:555.
345 345. Hunter AGW, Sharpe NF, Mullen M, et al. Ethical, legal, and practical concerns about recontacting patients to inform them of new information. In: Sharpe NF, Carter RF, eds. Genetic testing. care, consent and liability. New York: John Wiley & Sons, 2006.
346 346. Sirchia F, Carrieri D, Dheensa S, et al. Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe. Eur J Hum Genet 2018; 26:946.
347 347. Bombard Y, Mighton C. Recontacting clinical genetics patients with reclassified results: equity and policy challenges. Eur J Hum Genet 2019; 27:505.
348 348. Mink v. University of Chicago, 460F. Supp. 713 (N.D.Ill.1978).
349 349. Tresemer v. Barke, 86 Cal. App.3d 656, 150 Cal. Rptr 384 (1978).
350 350. Pelias MZ. Duty to disclose in medical genetics: a legal perspective. Am J Med Genet 1991; 39:347.
351 351. Hirschhorn K, Fleischer LD, Godmilow L, et al. Duty to re‐contact. Genet Med 1999; 1:171.
352 352. Shirts BH, Parker LS. Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information. Genet Med 2008; 10:778.
353 353. David KL, Best RG, Brenman LM, et al. Patient re‐contact after revision of genomic test results: points to consider – a statement of the American College of Medical Genetics and Genomic (ACMG). Genet Med 2019; 21:769.
354 354. Nance MA. Genetic counseling and testing for Huntington's disease: a historical review. Am J Med Genet B Neuropsychiatr Genet 2017; 174:75.
355 355. Borle K, Morris E, Inglis A, et al. Risk communication in genetic counseling: Exploring uptake and perception of recurrence numbers, and their impact on patient outcomes. Clin Genet 2018; 94:239.
356 356. Stuttgen K, Dvoskin R, Bollinger J, et al. Risk perception before and after presymptomatic genetic testing for Huntington's disease: not always what one might expect. Mol Genet Genomic Med 2018; 6:1140.
357 357. Ibisler A, Ocklenburg S, Stemmler S, et al. Prospective evaluation of predictive DNA testing for Huntington's disease in a large German center. J Genet Couns 2017; 26:1029.
358 358. Smit AK, Newson AJ, Best M, et al. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma. Eur J Hum Genet 2018; 26:1094.
359 359. McGarry A, McDermott MP, Kieburtz K, et al. Risk factors for suicidality in Huntington disease. Neurology 2019; 92:e1643.
360 360. Anderson KE, Eberly S, Marder KS, et al. The choice not to undergo genetic testing for Huntington disease: results from the PHAROS study. Clin Genet 2019; 96:28.
361 361. Tassicker RJ, Teltscher B, Trembath MK, et al. Problems assessing uptake of Huntington's disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17(1):66.
362 362. Morrision PJ, Harding‐Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011; 80(3):281.
363 363. Baig SS, Strong M, Quarrell OWJ. The global prevalence of Huntingtons disease: a systematic review and discussion. Neurodegener Dis Manag 2016; 6(4):331.
364 364. Baig SS, Strong M, Rosser E, et al. 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium. Eur J Hum Genet 2017; 25(11):1290.
365 365. Mendes Á, Paneque M, Clarke A, et al. Choosing not to know: accounts of non‐engagement with pre‐symptomatic testing for Machado‐Joseph disease. Eur J Hum Genet 2019; 27:353.
366 366. Cowley L. What can we learn from patients' ethical thinking about the right ‘not to know’ in genomics? Lessons from cancer genetic testing for genetic counselling. Bioethics 2016; 30:628.
367 367. Stark Z, Wallace J, Gillam L, et al. Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed? J Med Ethics 2016; 42:640.
368 368. Milunsky JM, Maher TA, Loose BA, et al. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease. Clin Genet 2003; 64:70.
369 369. MacLeod RTA, Frontali M, Evers‐Kiebooms G, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet 2013; 23:221.
370 370. Tassicker R, Savulescu J, Skene L, et al. Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal and ethical viewpoints. BMJ 2003; 326:331.
371 371. Van Rij MC, De Rademaeker M, Moutou C, et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet 2012; 20:368.
372 372. Bouchghoul H, Clément SF, Vauthier D, et al. Prenatal testing in Huntington disease: after the test, choices recommence. Eur J Hum Genet 2016; 24:1535.
373 373. Duncan RE, Foddy B, Delatycki MB. Refusing to provide a prenatal test: can it ever be ethical? BMJ 2006; 333:1066.
374 374. Wadrup F, Holden S, MacLeod R, et al. A case‐note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice. Eur J Hum Genet 2019; 27:1215.
375 375. Jones EF, Forrest JD, Henshaw SK, et al. Unintended pregnancy, contraceptive practice and family planning services in developed countries. Fam Plann Perspect 1988; 20:53.
376 376. Tarasoff v. Regents of the University of California, 551 P.2d 334 (Cal. 1976).
377 377. Stol YH, Menko FH, Westerman MJ, et al. Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists. J Med Ethics 2010; 36:391.
378 378. Menko FH, Aalfs CM, Henneman L, et al. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 2013; 12:319.
379 379. Lacroix M, Nycum G, Godard